• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Awardees
      • Committees
      • Sponsors
    • Cancer Policy Roundtable (CPR)
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • 2021 State of Survivorship Survey Results Briefing
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2021
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Your generous year-end donation will be matched $1 for $1    DONATE

New Health Insurance Exchanges

Meeting Consumer Expectations and Health Needs in the New Health Insurance Exchanges

June 12, 2014/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act, Care Coordination, Payment Reform, Quality Cancer Care NCCS News /by actualize

Cancer Policy Matters Guest Post by Tanisha Carino, Executive Vice President, Avalere Health

The Affordable Care Act provides an unprecedented opportunity for millions to gain coverage through the exchange marketplace by enrolling in a qualified health plan (QHP) that covers essential health benefits and limits financial exposure to excessive out-of-pocket costs.

Tanisha Carino

Guest Blog Post by Tanisha Carino, Avalere Health

More than 8 million individuals have signed up for a QHP to date, and over 60 percent of them selected low-cost Silver and Bronze plans, demonstrating that low premium prices are driving consumer plan selection in the market.  But what happens when these exchange enrollees need to access care?  Do these insurance products meet consumer expectations?

As the new exchange marketplace takes shape, plans are under tremendous pressure to price products competitively while also balancing the generosity of their benefits.  Avalere’s PlanScape analyzed exchange benefits using data released by the federal government for plans in the Federally-Facilitated Exchange and an in-depth review of the formulary design for a subset of plans participating in large exchange markets.

Based on Avalere’s analysis, monthly premiums for Silver plans average $263 for 27-year-olds to $439 for 50-year-olds nationwide. However, once they need to access their benefits, medical deductibles may be prohibitively high, averaging $4,959 and $3,132 for Bronze and Silver plans, respectively.  By comparison, the average medical deductible among employer plans that have a deductible is only $1,135.  While these deductibles are critical for plans to remain price competitive and meet the value of benefits required for each metal level, chronically ill patients may not be prepared for the up-front costs that will be required to meet the deductible.

In terms of formulary coverage, exchange plans cover a similar number of drugs as plans commonly sold in the employer market. However, exchange plans impose utilization management on self-administered oncology drugs at a higher rate than employer plans (43 percent and 30 percent, respectively), suggesting that providers will need to work with patients enrolled in exchange plans to file prior authorizations and help them access oncolytics.

As the exchange marketplace evolves, cancer patient advocacy organizations will play an instrumental role in ensuring that exchange enrollees have adequate access to needed cancer treatments and services.

Patient cost-sharing associated with oncology drugs on exchange plans can also present challenges for cost-sensitive patients.  Based on Avalere’s analysis, Silver plans commonly impose coinsurance – rather than a flat copay – for oncolytics, particularly for molecular target inhibitors and antiangiogenics.  Cancer patients in need of these treatments may shoulder higher costs than anticipated and may bear the bulk of those costs early in the calendar year before they meet their out-of-pocket caps. Assuming cancer patients can reach their cap though, they will benefit greatly from these new ACA out-of-pocket maximums ($6,350 for an individual in 2014), which will help prevent medical bankruptcy.

Lastly, to keep premiums down, most insurers designed narrow provider networks, some of which exclude leading cancer centers. Prior to a cancer diagnosis, consumers may not think to look for leading cancer centers when buying a plan, and even those who do may struggle to asses network breadth.  To date, only two states use searchable tools to determine if a patient’s provider is covered, highlighting the need for these tools to be widely available in other states.

As the exchange marketplace evolves, cancer patient advocacy organizations will play an instrumental role in ensuring that exchange enrollees have adequate access to needed cancer treatments and services.  This will include targeted advocacy efforts around:

  • Increasing plan transparency on coverage of drugs and providers so that consumers are aware of their exposure to cost-sharing;
  • Educating consumers about their options so that they can make informed coverage decisions; and
  • Building awareness among providers around exchange cost-sharing and utilization management so they can help patients access needed drugs and services.

Until consumer expectations align with the affordability and generosity found on exchange plans, patients shoulder the costly growing pains created by the new marketplace.

Tanisha Carino, Executive Vice President, oversees Avalere’s strategic advisory and research services for the nation’s leading life sciences companies. For close to a decade, Tanisha has worked with senior leadership in FORTUNE 500 companies to establish organizational goals and align their internal functions to capture opportunities and mitigate challenges related to evolving regulatory, evidence, and commercial trends. Follow Tanisha on Twitter: @tcarinoavalere.

About Avalere: Avalere Health is a strategic advisory company whose core purpose is to create innovative solutions to complex healthcare problems. Based in Washington, D.C., the firm delivers actionable insights, business intelligence tools and custom analytics for leaders in healthcare business and policy. Avalere’s experts span 180 staff drawn from Fortune 500 healthcare companies, the federal government (e.g., CMS, OMB, CBO and the Congress), top consultancies and nonprofits. Follow Avalere on Twitter: @avalerehealth.

Tags: affordable care act, cancer care, ePatient, exchange plans, payment reform, qualified health plans, quality
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
https://canceradvocacy.org/wp-content/uploads/New-Health-Insurance-Exchanges.jpg 378 315 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2014-06-12 15:02:022020-11-27 14:25:11Meeting Consumer Expectations and Health Needs in the New Health Insurance Exchanges

Latest News

Beyond the Checkbox: Cancer Survivorship Care Delivery in the Community - Dr. Crystal Labbato

Webinar – Beyond the Checkbox: Delivering Meaningful Cancer Survivorship Care in a Community Setting

May 20, 2022
Last week, NCCS hosted a conversation with cancer control expert and epidemiologist Otis Brawley, MD. NCCS CEO Shelley Fuld Nasso moderated the discussion. “We knew exactly who we wanted to be our first guest speaker in this series. Dr. Otis Brawley is a Bloomberg Distinguished Professor at Johns Hopkins University, an oncologist and an epidemiologist. [...]
Read more
https://canceradvocacy.org/wp-content/uploads/Beyond-the-Checkbox-Crystal-Labbato.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-05-20 13:39:272022-05-20 13:39:27Webinar – Beyond the Checkbox: Delivering Meaningful Cancer Survivorship Care in a Community Setting
Michelle Mollica PhD Webinar Survivorship Needs for People with Metastatic and Advanced Cancers

Webinar: Survivorship Needs for People Living with Advanced and Metastatic Cancers

May 6, 2022
Last week, NCCS hosted a conversation with cancer control expert and epidemiologist Otis Brawley, MD. NCCS CEO Shelley Fuld Nasso moderated the discussion. “We knew exactly who we wanted to be our first guest speaker in this series. Dr. Otis Brawley is a Bloomberg Distinguished Professor at Johns Hopkins University, an oncologist and an epidemiologist. [...]
Read more
https://canceradvocacy.org/wp-content/uploads/Webinar-Michelle-Mollica-Metastatic-Survivorship-Needs.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-05-06 11:32:162022-05-06 12:35:15Webinar: Survivorship Needs for People Living with Advanced and Metastatic Cancers

Erin McGee Ferrell: The Art of Cancer Advocacy

May 5, 2022
Advocate Spotlight May 2022 - Erin McGee Ferrell Erin McGee Ferrell’s cancer…
Read more
https://canceradvocacy.org/wp-content/uploads/Erin-McGee-Ferrell-Advocate-Spotlight-1200px.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2022-05-05 12:00:402022-05-05 12:03:28Erin McGee Ferrell: The Art of Cancer Advocacy

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.
  • About
    • Our Mission
    • Our History
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Awardees
      • Committees
      • Sponsors
    • Cancer Policy Roundtable (CPR)
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • 2021 State of Survivorship Survey Results Briefing
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2021
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

Dr. Patricia Ganz Talks About Common Cancer Survivorship Issues and Founding... FacebookProfile3 Patient-Centered Care WCOE: Patient-Centered Care, “The Fault in Our Stars” and Genetic...
Scroll to top
Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute